Fisher Asset Management LLC increased its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 20.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 197,000 shares of the company’s stock after purchasing an additional 34,000 shares during the quarter. Fisher Asset Management LLC owned approximately 0.40% of LivaNova PLC worth $13,802,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the stock. Quantitative Systematic Strategies LLC purchased a new stake in shares of LivaNova PLC during the third quarter worth about $284,000. Koch Industries Inc. purchased a new stake in shares of LivaNova PLC during the second quarter worth about $1,384,000. Ameritas Investment Partners Inc. grew its position in shares of LivaNova PLC by 33.3% during the second quarter. Ameritas Investment Partners Inc. now owns 17,044 shares of the company’s stock worth $1,043,000 after purchasing an additional 4,262 shares in the last quarter. California State Teachers Retirement System purchased a new stake in shares of LivaNova PLC during the second quarter worth about $5,264,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of LivaNova PLC by 59.0% during the second quarter. The Manufacturers Life Insurance Company now owns 97,791 shares of the company’s stock worth $5,986,000 after purchasing an additional 36,279 shares in the last quarter. Hedge funds and other institutional investors own 81.69% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “LivaNova PLC (LIVN) Shares Bought by Fisher Asset Management LLC” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.dispatchtribunal.com/2017/11/11/fisher-asset-management-llc-grows-holdings-in-livanova-plc-livn.html.
LIVN has been the subject of several research analyst reports. Needham & Company LLC upgraded LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a report on Thursday, September 14th. Piper Jaffray Companies restated an “overweight” rating and set a $75.00 price target on shares of LivaNova PLC in a report on Tuesday, September 12th. Jefferies Group LLC initiated coverage on LivaNova PLC in a report on Friday, September 8th. They set a “buy” rating and a $76.00 price target for the company. BidaskClub cut LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, ValuEngine upgraded LivaNova PLC from a “hold” rating to a “buy” rating in a report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. LivaNova PLC currently has a consensus rating of “Buy” and a consensus target price of $77.86.
LivaNova PLC (NASDAQ:LIVN) traded down $1.16 during trading hours on Friday, hitting $80.26. The stock had a trading volume of 197,900 shares, compared to its average volume of 393,715. The company has a market cap of $3,925.39, a price-to-earnings ratio of 23.46, a price-to-earnings-growth ratio of 2.45 and a beta of 0.52. LivaNova PLC has a 1-year low of $40.83 and a 1-year high of $81.85. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.03 and a quick ratio of 1.42.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.17. The business had revenue of $309.70 million during the quarter, compared to analyst estimates of $301.22 million. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period last year, the company earned $0.78 EPS. analysts expect that LivaNova PLC will post 3.33 earnings per share for the current year.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $68.55, for a total value of $68,550.00. Following the completion of the sale, the director now directly owns 57,296 shares of the company’s stock, valued at approximately $3,927,640.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 3,000 shares of company stock valued at $203,890 over the last ninety days. Corporate insiders own 0.28% of the company’s stock.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.